Invent Medic has received notice of allowance in the USA for a patent application in the USA for the company’s product Efemia bladder support. The patent will be valid until 2029.
The patent application (15/243834) covers a method for using the company’s product Efemia bladder support to reduce stress urinary incontinence (SUI). It will thus extend and strengthen the granted Efemia base patent in the USA. The base patent is also granted in Sweden and Europe.
”This decision will strengthen the patent protection for Efemia in the USA, which is important for our plans to launch Efemia in North America in the future. Invent Medic has implemented an ambitious and proactive global strategy for immaterial rights, and the USA is one of our most important markets. In addition to patents, this strategy includes design and brand protection so that we can achieve optimal scope and duration for the protection of our product portfolio,” says Invent Medic’s CEO Karin Bryder.
When issuing a notice of allowance, the patent office has the intention to grant the patent application following the final steps of the procedure, such as payment of the patent fee.